Aug 2026· Frontiers in Microbiology· Vol 17· 0 citations· 90 references
Medicine
TL;DR
A comprehensive narrative review of foundational research on the vaginal microbiome in cervical cancer patients, correlations with metabolites, epidemiological characteristics, diagnostic applications, therapeutic strategies, and ongoing controversies and challenges is offered.
Abstract
As the fourth most common malignancy among women globally, cervical cancer is intimately linked to persistent high-risk human papillomavirus (HPV) infection; however, HPV infection is not the sole pathogenic factor. Recent studies have revealed that the composition, dynamics, and metabolic products of the vaginal microbiota play pivotal roles in the occurrence, progression, diagnosis, and treatment of cervical cancer. This article offers a comprehensive narrative review of foundational research on the vaginal microbiome in cervical cancer patients, correlations with metabolites, epidemiological characteristics, diagnostic applications, therapeutic strategies, and ongoing controversies and challenges. Basic research demonstrates that increased vaginal microbial diversity and reduced Lactobacillus abundance are associated with cervical cancer progression, wherein pathogenic bacteria such as Fusobacterium spp. and Sneathia spp. have been associated with tumorigenesis through immunosuppression and inflammatory mechanisms. Metabolites like 3-hydroxybutyrate and sphingolipids show potential as diagnostic biomarkers and therapeutic targets. Epidemiological studies reveal associations between variations in the vaginal microbiota across different populations (e.g., African, Latina) and cervical cancer risk. In diagnostics, detection methods based on the vaginal microbiome can enhance early screening efficiency, with novel sequencing technologies combined with artificial intelligence demonstrating promising application prospects. Therapeutically, interventions such as probiotics and microbiota modulation may improve patient outcomes. Nonetheless, current research faces challenges, including an unclear causal relationship between the microbiota and HPV infection and a lack of standardization in detection techniques. Future endeavors necessitate multi-omics integration, large-scale longitudinal studies, and precise intervention strategies to facilitate the clinical translation of vaginal microbiome research into cervical cancer prevention and treatment.
Cervical cancer is the most common malignancy of the female reproductive system and a leading cause of cancer-related mortality among women aged 20–39 years, posing a significant global health burden for women. Persistent infection with high-risk human papillomavirus (HPV) is widely recognized as the primary etiologica...
Wen-Dong Wang, Tiantian Yu· Frontiers in Cellular and In...· 0 citations
Persistent high-risk human papillomavirus (HR-HPV) infection serves as the core prerequisite for cervical intraepithelial neoplasia (CIN) and invasive cervical cancer. Accumulated translational evidence confirms that vaginal microecological homeostasis dominated by protective Lactobacillus strains fundamentally governs...
Bladder cancer is a prevalent urinary malignancy with high global incidence and mortality. Despite advances in diagnosis and treatment, challenges persist, particularly due to high recurrence rates and unpredictable progression. Recent evidence highlights the role of urinary tract microbiota in BC initiation, progressi...
Zhaoyang Sheng, Jinpeng Zhu, Jian-Ming Sun et al.· Frontiers in Cellular and In...· 0 citations
Persistent infection with high-risk Human Papillomavirus (hrHPV) is the central etiological factor in cervical cancer, while the host vaginal microenvironment plays a critical role in disease progression. Lactobacillus iners is one of the most widely distributed lactobacilli in the vagina. Because of its unique biologi...
Xiao-Dan Zhang· Journal of Clinical Technolo...· 0 citations
ABSTRACT Although the etiology of cervical cancer has been partially established, its pathogenesis remains a key research focus. Specific studies on the genital tract microbiota of cervical cancer patients in Southern China are still scarce. To address this research gap, the present study collected genital tract microb...
Guo-Jiao Wang, Xiao-Tong Liu, Zi-Mo Wang et al.· MicrobiologyOpen· 0 citations
Important gaps remain in our understanding of the vaginal virome. Its composition, interactions with the bacterial microbiome and host immune system, and implications for vaginal homeostasis, human papillomavirus (HPV) persistence, and obstetric outcomes remain incompletely defined. The vaginal virome is a dynamic comp...
J. Eleutério, P. Giraldo, R. Eleutério et al.· Microorganisms· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.